Sung Lee

Chief Financial Officer

  • Year of birth 1970
  • Nationality American
  • Management Board Member of MorphoSys AG since 2021
  • End of current period 2024

Sung Lee leads all corporate finance functions of the company. 

Sung has more than 20 years of finance leadership experience in biopharmaceutical and technology businesses. He joined MorphoSys from Sangamo Therapeutics, Inc., where he served as Chief Financial Officer. Prior to that role, Sung spent nearly 14 years at Gilead Sciences where he most recently led the global Financial Planning & Analysis and Investor Relations functions. 

Sung started his career in the tax advisory business at PriceWaterhouseCoopers LLP. He received a Master of Business Taxation from the University of Southern California and a B.A. in Economics from the University of California, Irvine.